Definitive Contract W81XWH17C0065
- Not listed
- Xequel Bio, Inc., doing business as FSR, was awarded a $749,999 firm fixed price definitive contract from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to support research under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 seeks host-directed therapeutic candidates to aid long-term outcomes from lung injury. Under the contract, FSR will pursue safety review of such...
- This federal contract award, W81XWH16C0176, was issued by the Defense Health Agency (DHA) to Aptitude Medical Systems Inc., a small business, under the SBIR (Small Business Innovation Research) program. The contract is for a Phase II research and development project focused on developing diagnostic testing products and services for the government. The contract has a ceiling value of $999,990.51 and was awarded on September 23, 2016, with a final completion date of February 27, 2019. Aptitude...
- <p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>
- This is a $999,793.02 fixed-price level of effort contract awarded by the U.S. Army Medical Command to X-Therma Inc., a minority-owned, woman-owned small business. The contract is for the ARMY SBIR PHASE II PROPOSAL NO. A2-6795 titled "ON-DEMAND CELL AND TISSUE BIOLOGICS FOR MASS CASUALTY RESPONSE" under TOPIC NUMBER A16-050. The contract is set aside for small businesses and has an ultimate completion date of August 15, 2020. Through this SBIR Phase II contract, X-Therma Inc. is...
- This is a $1,009,937.61 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to X-Therma Inc., a minority-owned, woman-owned small business. The contract is for the development of advanced cryoprotectants and their application to the preservation of porcine kidneys ex vivo at sub-zero temperatures, with the goal of significantly extending the ischemia window of human-sized organs up to 120 hours. This work is also supported by additional grants...
- This is a Cost Plus Fixed Fee contract awarded by the Defense Health Agency (DHA) under the Small Business Innovation Research (SBIR) program. The prime contractor is TDA Research, Inc., a for-profit subchapter S corporation located in Wheat Ridge, Colorado. The contract was set aside for small businesses and has a ceiling value of $1,996,362.19. It covers SBIR Phase II research and development efforts, which typically involve further development and demonstration of technologies that showed...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The $1,000,000.00 contract is for the development of a product or technology under the SBIR program. As a Phase II award, this indicates the company previously received a Phase I contract for preliminary research and development. The contract has a cost-plus-fixed-fee pricing type and a period of...
- This is a Small Business Innovation Research (SBIR) Phase I research and development contract awarded by the Defense Health Agency (DHA) to SPZ Technologie LLC, a for-profit limited liability company. The $162,326.22 firm fixed-price contract is for the development of a "Novel Cell-Based Biosensor for Rapid Field Water Toxicity Detection" under Topic DHA191-006. The contract was set aside for small businesses and has a completion date of February 7, 2020. As an SBIR Phase I award, this...
- This federal contract award was made by the Defense Health Agency (DHA) to Erivan Bio, LLC, a for-profit limited liability company, for a Small Business Technology Transfer (STTR) Phase I research project titled "Novel Scalable Loading of Antibiotics in Exosomes for Bacterial Wound Infection Prevention". The contract has a firm fixed price of $249,981.86 and a completion date of September 22, 2024. This STTR Phase I award supports research and development to develop a novel approach...
- <p>This is a $1,219,810.46 fixed-price level of effort contract awarded by the Department of the Army Medical Command to Myexposome Inc., a for-profit small business, for a Small Business Innovation Research (SBIR) Phase II research project. The contract was awarded on March 31, 2017 and is scheduled for completion on April 30, 2020. The contract is set aside for exclusive participation by small businesses.</p>
This federal contract award, W81XWH17C0065, was issued by the Defense Health Agency (DHA) to Xequel Bio, Inc., a for-profit small business, under the SBIR (Small Business Innovation Research) Program Phase II. The $999,960.15 cost-reimbursement contract supports Xequel Bio's research and development of innovative biomedical solutions, including therapies for infectious disease, medical countermeasures, regenerative medicine, and battlefield medicine. Xequel Bio has been awarded several previous federal contracts and grants from agencies such as the National Institutes of Health, the HHS Office of the Assistant Secretary for Preparedness and Response, and the Defense Health Agency, to advance the development of various therapeutic candidates, diagnostics, and medical devices. This specific SBIR Phase II award is intended to further the company's work in these areas, which are aligned with key priorities for the U.S. Department of Defense and Department of Health and Human Services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | ($550k) | 1/16/25 | |
| P00003 | Funding Only Action | ($1) | 2/16/22 | |
| P00002 | Other Administrative Action | $0 | 11/18/21 | |
| P00001 | Supplemental Agreement for work within scope | $550.0k | 6/25/21 | |
| Not listed | Not listed | $1.0m | 9/20/17 |